Therapeutic options in dementia

Journal of Neurology

Volumn 247, Issue 3, 2000, Pages 163-168

  Parnetti, Lucilla ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Alzheimer's disease; Behavioral disturbances; Dementia; Pharmacological treatment

Indexed keywords

ALPHA TOCOPHEROL; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; METRIFONATE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; RIVASTIGMINE; SELEGILINE; TACRINE;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; COGNITION; DAILY LIFE ACTIVITY; DEMENTIA; DETERIORATION; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HUMAN; INSTITUTIONALIZATION; LIVER TOXICITY; PERSONALITY; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SIDE EFFECT;

EID: 0034071642     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050556     Document Type: Review

References (8)

1. 1. American Psychiatric Association (1997) Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 154:1-39
2. 2. Knopman D, Schneider L, Davis K, Talwalker S, Smith F, Hoover T, Gracon S (1996) Long-term tacrine treatment: effects on nursing home placement and mortality. Tacrine Study Group. Neurology 47:166-177
3. 3. Parnetti L, Senin U, Mecocci P (1997) Cognitive enhancement therapy for Alzheimer's disease. The way forward. Drugs 53:752-768
4. 4. Rogers SL, Friedhoff LT (1998) Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol 8:67-75
5. 5. Sano M, Ernesto C, Thomas RG, Klauber MR Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-to-copherol, or both as treatment for Alzheimer's disease. N Engl J Med 336: 1216-1222
6. 6. Schneider LS, Farlow MR, Henderson VW, Pogoda JM (1996) Effects of estrogen replacement therapy on response to tacrine in patients with alzheimer's disease. Neurology 6:1580-1584
7. 7. Spencer CM, Noble S (1998) Rivastigmine. A review of its use in Alzheimer's disease. Drugs Aging 13:391-411
8. 8. Tanaka K, Ogawa N, Asanuma M, Kondo Y, Mori A (1994) Chronic administration of acetylcholinesterase inhibitor in the senescent rat brain. Neurobiol Aging 15:721-725